REFERENCES
- Littman B A, Smotrich D B, Stillman R J. Endometriosis. Principles and Practice of Endocrinology and metabolism, 2nd ed., K L Becker. J. B. Lippincott, Philadelphia 1995; 906–909
- Swisher D K, Tague R M, Seyler D E. Effects of the selective estrogen receptor modulator raloxifene on explanted uterine growth in rats. Drug Dev Res 1995; 36: 43–45
- Buelke-Sam J, Bryant H U, Francis P C. The selective estrogen receptor modulator, raloxifene: An overview of nonclinical pharmacology and reproductive and developmental testing. Reprod. Toxicol 1998; 12(3)217–221, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Okada H, et al. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J Pharmacol Exp Ther 1987; 244(2)744–750
- Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M, Viganò P. Endometriosis: Novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002; 78(4)665–678, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rajkumar K, Schott P W, Simpson C W. The rat as an animal model for endometriosis to examine recurrence of ectopic endometrial tissue after regression. Fertil Steril 1990; 53(5)921–925, [PUBMED], [INFOTRIEVE]
- Vernon M W, Wilson E A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985; 44(5)684–694, [PUBMED], [INFOTRIEVE]
- Zanagnolo V L, et al. Time-related effects of GnRH-a in experimentally induced endometriosis in the rat. Fertil Steril, 55(2)411–415
- Khovidunkit W, Shoback D M. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med 1999; 130: 431–439, [CSA]
- Sharpe-Timms K L. Basic research in endometriosis. Obstet Gynecol Clin North Am 1997; 24(2)269–290, [PUBMED], [INFOTRIEVE], [CROSSREF]